Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency

The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, is pleased to announce the appointment of Kevin Xu to its Independent Citizens’ Oversight Committee (ICOC), the official governing Board of the agency.

Xu is CEO of MEBO International, an intellectual property management company responsible for managing “Human Body Regenerative Restoration Science” and Skingenix, a California-based organization exclusively working on drug development in the field of damaged organ regeneration.

“It is a privilege to join CIRM’s board,” says Xu. “I look forward to collaborating with a passionate group of experts dedicated to advancing science and research to improve lives.”

Xu brings a wealth of knowledge and leadership experience to his new role. He was appointed to serve by then California Governor Jerry Brown on the California- China Trade and Investment Advisory Group and on a key advisory board of California-China trade office. He is the Executive Board member and Co-Chair of the International Committee, Bay Area Council, a member of Los Angeles County Mental Health Commission and member of the International Policy Committee of U.S. Chamber of Commerce.

“We are delighted to welcome Kevin as an invaluable addition to the ICOC,” says Vito Imbasciani, PhD, MD, Chair of the CIRM Board. “His outstanding accomplishments, passion for innovation and dedication to advancing science align seamlessly with our mission.”

In addition to his advisory roles at several organizations, Xu serves as a member of the Clinton Global Initiative, the Forbes Non-Profit Council, the Fortune CEO Initiative and the Young Entrepreneur Council (YEC). He is the founder of the National Rongxiang Xu Foundation, the Human Heritage Project and California Fight Against Coronavirus (CFAC). He is also the director of Beijing Rongxiang Regenerative Medicine Laboratory, former member institute of the United Nations Academic Impact (UNAI), and President of International Society of Regenerative Medicine and Wound Repair (ISRMWR).

Xu earned a BA in neuroscience from the University of Southern California (USC) where he was awarded the USC Young Alumni Merit Award.

One thought on “Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency

  1. Excellent article! Insightful content with comprehensive information. This blog contains incredible information. This blog clearly defines stem cell gene therapy, and it looks forward to working with a passionate group of experts dedicated to advancing science and research to improve people’s lives. This is a very well written article.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.